ArticleThe American journal of case reports2025
Invasive Gastrointestinal Mucormycosis Presenting as Neutropenic Enterocolitis: A Case Report.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Gastrointestinal mucormycosis is an underrecognized and underreported fungal infection with a high mortality rate. Diagnosis is often confounded by a non-specific constellation of signs and symptoms. We present a case of neutropenic colitis and ileocecal perforation secondary to gastrointestinal mucormycosis. CASE REPORT The patient was a 19-year-old man recently diagnosed with B-cell acute lymphoblastic leukemia, on active chemotherapy. He presented with abdominal pain and tenderness, and a contrast-enhanced CT revealed neutropenic colitis. Despite broad-spectrum antibiotics, his condition worsened, prompting reassessment. Follow-up CT showed bowel ischemia and a pelvic collection. He underwent an emergency laparotomy, which revealed destruction of the anterior cecal wall and detachment from the terminal ileum and ascending colon. Ileocecal resection was performed and histopathologic examination demonstrated angioinvasive fungal elements consistent with Mucor spp. He was diagnosed with gastrointestinal mucormycosis and promptly started on amphotericin intravenously. He improved over the next 2 weeks and was discharged with a plan to continue his 6-week course as an outpatient, followed by oral posaconazole maintenance therapy. Several weeks later, his infection relapsed secondary to non-compliance. He underwent repeat surgical debridement and antimicrobial therapy was restarted with intravenous amphotericin and Isavuconazole. He successfully completed 6 weeks of treatment and was transitioned to oral Isavuconazole prophylaxis. He remained stable and relapse-free at 6 months following his second procedure. CONCLUSIONS The case highlights the importance of early recognition of patients at risk for this infection, maintaining a high index of suspicion, and employing aggressive medical and surgical management strategies to avoid mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.